title: [Clinical courses of two male siblings on hemodialysis for Fabry disease ].
abstract: Fabry disease is an X-linked recessive disease resulting from a deficiency of the lysosomal hydrolase alpha-galactosidase A. In male patients with the classic hemizygous form, acroparesthesias, hypohidrosis, corneal opacities, and dysfunction of the heart, brain, and kidney are observed. Recently, it was reported that 0.5-1.2% of male chronic hemodialysis (HD) patients were diagnosed as having Fabry disease based on the measurement of alpha-galactosidase A activity. Fabry disease is thought to be an important cause of end-stage renal disease. There are a few reports of patients with Fabry disease on long-term HD. Here we report two male siblings with classical type Fabry disease on HD. They had acroparesthesias, and hypohidrosis. Their mother had severe heart failure due to a heterozygous form of Fabry disease. Case 1 is a 44-year-old male. He had mid-cerebral apoplexy at 30 years of age. He started maintenance HD in 2000. Remarkable left ventricular hypertophy and conduction disorders of the heart were found. In 2004, he collapsed and ventricular-tachycardia and severe hypoxic brain damage were found. Now his consciousness level has been in the range of 100 to 300 on the Japan Coma Scale. Case 2 is a 40-year-old male. He started maintenance HD in 1993. Malnutrition due to chronic diarrhea and severe ischemic change in the brain were found. In 1998, he had severe joint pain of shoulders and fingers with ectopic calcifications detected by X ray. The ectopic calcifications were extended to the whole body. In 2004, his dementia by ischemic change in the brain has rapidly progressed. In conclusion, cardiovascular complications, cerebrovascular manifestations, painful ectopic carcifications, and chronic diarrheas in our patients were considered to be specific symptoms of Fabry disease. Young HD patients with these symptoms will need to be examined for Fabry disease.
authors.affiliation: Department of Nephrology, Akebono Clinic, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
authors.forename: Kazuko
authors.initials: K
authors.lastname: Itoh
authors.forename: Motoko
authors.initials: M
authors.lastname: Tanaka
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Matsushita
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Miyamura
authors.forename: Kenroh
authors.initials: K
authors.lastname: Nishida
authors.forename: Eiichi
authors.initials: E
authors.lastname: Araki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nonoguchi
authors.forename: Kimio
authors.initials: K
authors.lastname: Tomita
mesh_terms: D000328:Adult; D041321:Chromosomes, Human, X / Q000235:genetics; D000795:Fabry Disease / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy*; D005808:Genes, Recessive; D006801:Humans; D008297:Male; D006435:Renal Dialysis; D035781:Siblings; D000519:alpha-Galactosidase / Q000008:administration & dosage
chemical_list: D000519:alpha-Galactosidase